Insight

Jordan Hansford: The importance of rigorous trials with “new” and novel agents

Photo of Jordan Hansford from vicpcc.org

Aug 11, 2024, 12:18

Jordan Hansford: The importance of rigorous trials with “new” and novel agents

Jordan Hansford, McClurg Brain Cancer Fellow at SAHMRI, shared on X about a recent paper titled “Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201” published in Journal of Clinical Oncology.

Authors: Jordan Hansford et al.

The importance

“Our review out in Journal of Clinical Oncology on the importance of rigorous trials with ‘new’ and novel agents led by Prof Eric Bouffet Vijay, Ramaswamy, Gauthier Bouche, Nada Jabado and I.”

Source: Jordan Hansford/X

Adriana Fonseca Amar Gajjar cancer Christopher Tinkle Darren Hargrave David Ashley David Eisenstat David Ziegler Eric Bouffet Gauthier Bouche Giles Robinson Jordan Hansford Journal of Clinical Oncology Maryam Fouladi Maura Massimino Nada Jabado Nicholas Foreman Nicholas Gottardo Olaf Witt OncoDaily Oncology Paul Fisher SAHMRI Sam Moloney Stefan Pfister Stefan Rutkowski Ute Bartels Vijay Ramaswamy

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage